Endovascular Therapy of TASC-D Lesion in Critical Limb Ischemia

Authors

Ahmed Amro, MD, Marshall University school of MedicineFollow
Alaa Gabi, MD, Marshall University school of MedicineFollow
Dr. Mehiar El-Hamdani, MD, FACC, FSCAI, Marshall University School of MedicineFollow

Keywords

Critical limb ischemia, TASC-D lesion, Endovascular intervention, Peripheral artery disease, Aortoiliac

Disciplines

Cardiology | Medical Education | Medicine and Health Sciences

Abstract

CLI (Rutherford class IV-VI) is a terminal stage of peripheral artery disease (PAD); it is defined by the presence of resting pain and/or tissue loss for at least two weeks that may require urgent revascularization to promote healing and prevent limb loss.For patients with infrarenal aortoiliac occlusive disease, the revascularization options are surgery like aortofemoral bypass and axillofemoral bypass or percutaneous intervention. Aortoiliac and aortofemoral bypass procedures are associated with 74% to 95% 5-year patency rates, respectively, which are comparable but not superior to percutaneous therapies.These operations may imply a significant morbidity and mortality on CLI patients who usually have multiple comorbid conditions and are considered high risk patients.

Recommended Citation

Amro, MD A, Gabi, MD A, El-Hamdani, MD, FACC, FSCAI D. Endovascular Therapy of TASC-D Lesion in Critical Limb Ischemia. Marshall J Med. 2016; 2(3): 32 DOI: